The role of sensitization to Malassezia sympodialis in atopic eczema

Chemical Immunology and Allergy

Volumn 91, Issue , 2006, Pages 98-109

  Schmid Grendelmeier, Peter ^a   Scheynius, Annika ^b   Crameri, Reto ^c  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b KAROLINSKA INSTITUTE   (Sweden)

^c SWISS INSTITUTE OF ALLERGY AND ASTHMA RESEARCH SIAF   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ANTIINFLAMMATORY AGENT; CALCINEURIN INHIBITOR; CYTOKINE; IMMUNOGLOBULIN E; ITRACONAZOLE; MANGANESE SUPEROXIDE DISMUTASE; PIMECROLIMUS; STEROID; TACROLIMUS;

ATOPIC DERMATITIS; CELLULAR IMMUNITY; CLINICAL TRIAL; CROSS REACTION; CRYPTOCOCCUS; DENDRITIC CELL; DNA SCREENING; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LANGERHANS CELL; MALASSEZIA; MALASSEZIA SYMPODIALIS; MOLECULAR MIMICRY; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRICK TEST; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN STRUCTURE; REVIEW; SKIN CARE; SKIN FUNCTION; SKIN PERMEABILITY; SKIN SENSITIZATION; SYMPTOM; T LYMPHOCYTE;

EID: 30744441412     PISSN: 16602242     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000090246     Document Type: Review

References (41)

1. Schultz Larsen F, Diepgen T, Svensson A: The occurrence of atopic dermatitis in North Europe: An international questionnaire study. J Am Acad Dermatol 1996;34:760-764.
2. ISAAC - The international Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee: Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivities, and atopic eczema: ISAAC. Lancet 1998;351:1225-1232.
3. Leung DY, Bieber T: Atopic dermatitis. Lancet 2003;361:151-160.
4. Scheynius A, Johansson C, Buentke E, Zagari A, Linder MT: Atopic eczema/dermatitis syndrome and Malassezia. Int Arch Allergy Immunol 2002;127:161-169.
5. Novak N, Bieber T: Allergic and nonallergic forms of atopic disease. J Allergy Clin Immunol 2003;112:252-262.
6. Wuthrich B, Schmid-Grendelmeier P: The atopic eczema/dermatitis syndrome: Epidemiology, natural course, and immunology of the IgE-associated ('extrinsic') and the nonallergic ('intrinsic') AEDS. J Investig Allergol Clin Immunol 2003;13:1-5.
7. Fartach M: Epidermal barrier in disorders of the skin. Microsc Res Tech 1997;38:361-372.
8. Gfesser M, Rakoski J, Ring J: The disturbance of epidermal barrier function in atopy patch test reactions in atopic eczema. Br J Dermatol 1996;135:560-565.
9. Imayama S, Shimozono Y, Hoashi M, Yasumoto S, Ohta S, Yoneyama K, Hori Y: Reduced secretion of IgA to skin surface of patients with atopic dermatitis. J Allergy Clin Immunol 1994;94:195-200.
10. Cho SH, Strickland I, Boguniewicz M, Leung DY: Fibronectin and fibrinogen contribute to the enhanced binding of Staphylococcus aureus to atopic skin. J Allergy Clin Immunol 2001;108:269-274.
11. Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, Gallo RL, Leung DY: Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002;347:1151-1160.
12. Sugita T, Saito M, Ito T, Kato Y, Tsuboi R, Takeuchi S, Nishikawa A: The basidiomicetous yeast Cryptococcus diffluens and C. liquefaciens colonize the skin of patients with atopic dermatitis. Microbiol Immunol 2003;47:945-950.
13. Brander KA, Borbléy P, Crameri R, Pichler WJ, Helbling A: IgE-binding, proliferative responses and skin test reactivity to Cop c 1, the first recombinant allergen from the basidiomycete Coprinus comatus. J Allergy Clin Immunol 1999;104:630-636.
14. Fischer B, Yawalkar N, Brander KA, Pichler WJ, Helbling A: Coprinus comatus (shaggy cap) is a potential source of aeroallergen that may provoke atopic dermatitis. J Allergy Clin Immunol 1999;104:836-841.
15. Faergemann J: Pityrosporum species as a cause of allergy and infection. Allergy 1999;54:413-419.
16. Midgley G: The lipophilic yeasts: State of the art and prospects. Med Mycol 2000;38(suppl 1):9-16.
17. Midgley G: The diversity of Pityrosporum (Malassezia) yeasts in vivo and in vitro: Mycopathologia 1989;106:143-153.
18. Sandström Falk MH, Tengvall Linder M, Johansson C, Bartosik J, Bäck O, Särnhult T, Wahlgren CF, Scheynius A, Faergemann J: The prevalence Malassezia yeasts in patients with atopic dermatitis, seborrhoeic dermatitis and healthy controls. Acta Derm Venereol 2005;85:17-23.
19. Hirai A, Kano R, Makimura K, Duarte ER, Hamdan JS, Lachance MA, Yamaguchi H, Hasegawa A: Malassezia nana sp. nov., a novel lipid-dependent yeast species isolated from animals. Int J Syst Evol Microbiol 2004;54:623-627.
20. Sugita T, Tajima M, Takashima M, Amaya M, Saito M, Tsuboi R, Nishikawa A: A new yeast, Malassezia yamatoensis, isolated from a patient with seborrheic dermatitis, and its distribution in patients and healthy subjects. Microbiol Immunol 2004;48:579-583.
21. Gabrielsson S, Buentke E, Liedén A, Schmidt M, D'Amato M, Tengvall-Linder M, Scheynius A: Malassezia sympodialis stimulation differently affects gene expression in dendritic cells from atopic dermatitis patients and healthy individuals. Acta Derm Venereol 2004;84:1-7.
22. Donnarumma G, Paoletti I, Buommino E, Orlando M, Tufano MS, Baroni A: Malassezia furfur induces the expression of beta-defensin-2 in human keratinocytes in a protein kinase C-dependent manner. Arch Dermatol Res 2004;295:474-481.
23. Johansson S, Karlström K: IgE-binding components in Pityrosporum orbiculare identified by an immunoblotting technique. Acta Derm Venereol 1991;71:11-16.
24. Zagari A, Doekes G, van Ieperen-van Dijk AG, Landberg E, Härfast B, Scheynius A: Influence of culture period on the allergenic composition of Pityrosporum orbiculare extracts. Clin Exp Allergy 1995;25:1235-1245.
25. Crameri R, Kodzius R, Konthur Z, Lehrach H, Blaser K, Walter G: Tapping allergen repertoires by advanced cloning technologies. Int Arch Allergy Immunol 2001;124:43-47.
26. Weichel M, Flückiger S, Crameri R: Molecular characterisation of mould allergens involved in respiratory complications. Recent Res Dev Resp Crit Care Med 2002;2:29-45.
27. Flückiger S, Fijten H, Whitley P, Blaser K, Crameri R: Cyclophilins, a new family of cross-reactive allergens. Eur J Immunol 2002;32:10-17.
28. Andersson N, Rasool O, Schmidt M, Kodzius R, Flückiger S, Zagari A, Crameri R, Scheynius A: Cloning, expression and characterization of two new IgE-binding proteins from the yeast Malassezia sympodialis with sequence similarities to heat shock proteins and manganese superoxide dismutase. Eur J Biochem 2004;271:1885-1894.
29. Huang X, Johansson SGO, Zagari A, Nordwall SL: Allergen cross-reactivity between Pityrosporum orbiculare and Candida albicans. Allergy 1995;50:648-656.
30. Werfel T, Kapp A: Environmental and other major provocation factors in atopic dermatitis. Allergy 1998;53:731-739.
31. Johansson SGO, Bieber T, Dahl R, Friedmann, PS, Lanier BQ, Lockey RF, Motala C, Ortega Martell JA, Platts-Mills TA, Ring J, Thien F, Van Cauwenberge P, Williams HC: Revised nomenclature for allergy for global use. Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004;113:832-836.
32. Schmid-Grendelmeier P, Simon D, Simon HU, Akdis CA, Wüthrich B: Epidemiology, clinical features, and immunology of the 'intrinsic' (non-IgE-mediated) type of atopic dermatitis (constitutional dermatitis). Allergy 2001;56:841-849.
33. Bruynzeel-Koomen C, van Wichen DF, Toonstra J, Berrens L, Bruynzeel PL: The presence of IgE molecules on epidermal langerhans cells in patients with atopic dermatitis. Arch Dermatol Res 1986;278:199-205.
34. Svejgaard E, Larsen PO, Deleuran M, Ternowitz T, Roed-Petersen J, Nilsson J: Treatment of head and neck dermatitis comparing itraconazole 200 mg and 400 mg daily for 1 week with placebo. J Eur Acad Dermatol Venereol 2004;18:445-449.
35. Valenta R, Seiberler S, Natter S, Mahler V, Mossabeb R, Ring J, Stingl G: Autoallergy: A pathogenetic factor in atopic dermatitis? J Allergy Clin Immunol 2000;105:432-437.
36. Crameri R, Faith A, Hemmann S, Jaussi R, Ismail C, Menz G, Blaser K: Humoral and cell-mediated autoimmunity in allergy to Aspergillus fumigatus. J Exp Med 1996;184:265-270.
37. Mayer C, Appenzeller U, Seelbach H, Achatz G, Oberkofler H, Breitenbach M, Blaser K, Crameri R: Humoral and cell-mediated autoimmune reactions to human acidic ribosomal P2 protein in individuals sensitized to Aspergillus fumigatus. J Exp Med 1999;189:1507-1512.
38. Flückiger S, Limacher A, Glaser AG, Scapozza L, Crameri R: Structural aspects of cross-reactive allergens. Rec Res Dev Allergy Clin Immunol 2004;5:57-75.
39. Flückiger S, Mittl PRE, Scapozza L, Fijten H, Folkers G, Grütter MG, Blaser K, Crameri R: Comparison of the crystal structures of the human manganese superoxide dismutase and the homologous Aspergillus fumigatus allergen at 2-Å resolution. J Immunol 2002;168:1267-1272.
40. Schmid-Grendelmeier P, Flückiger S, Disch R, Trautmann A, Wüthrich B, Blaser K, Scheynius A, Crameri R: IgE-mediated and T-cell-mediated autoimmunity against manganese superoxide dismutase in atopic dermatitis. J Allergy Clin Immunol 2005;115:1068-1075.
41. Mayer C, Hemmann S, Faith A, Blaser K, Crameri R: Cloning, production, characterization and IgE cross-reactivity of different manganese superoxide dismutases in individuals sensitized to Aspergillus fumigatus. Int Arch Allergy Immunol 1997;113:213-215.